With or without insurance
Receive GLP-1 medications, including Zepbound™, at an affordable price with or without insurance.
20% Average Weight Loss
Zepbound™ patients lose 20% of their body weight on average in under a year.
Science-Backed
GLP-1 medications, like Zepbound™ are FDA-approved for type 2 diabetes and have proven effective for weight loss.
Zepbound™ is a GLP-1/GIP medication FDA-approved to treat obesity & facilitate weight loss. It has been shown to help people lose an average of 20% of their body weight.*
FDA-approved
2.5 mg per injection
*This estimate derives from Eli Lilly’s SURMOUNT-4 clinical trial results which showed 20% average weight loss over 36 weeks among people utilized a maximum tolerated dose of 10 mg or 15 mg once-weekly. The starting dose of 2.5 mg Zepbound was increased by 2.5 mg every four weeks until maximum tolerated dose was achieved. Treatment was given in addition to diet and exercise.
No virtual appointments or in-office visits; online
Tirzepatide, active ingredient in Zepbound™, is available if Zepbound™ not covered by insurance
$75 for Zepbound 12 pens
One-time payment in full at checkout. Not a subscription.